"10.1371_journal.pone.0149628","plos one","2016-02-23T00:00:00Z","Claire Rooney; Catherine Geh; Victoria Williams; Johannes M Heuckmann; Roopika Menon; Petra Schneider; Katherine Al-Kadhimi; Michael Dymond; Neil R Smith; Dawn Baker; Tim French; Paul D Smith; Elizabeth A Harrington; J Carl Barrett; Elaine Kilgour","AstraZeneca, Oncology Innovative Medicines, Alderley Park, Macclesfield, United Kingdom; AstraZeneca, Personalised Healthcare and Biomarkers Innovative Medicines, Alderley Park, Macclesfield and Melbourn, Cambridge, United Kingdom; Blackfield AG, Cologne, Germany; AstraZeneca, Discovery Sciences Innovative Medicines, Alderley Park, Macclesfield, United Kingdom; AstraZeneca Oncology Innovative Medicines, Gatehouse Park, Waltham, Massachusetts, United States of America","Conceived and designed the experiments: CR CG VW JMH KAK TF PDS EAH JCB EK NRS DB. Performed the experiments: CR CG VW RM PS KAK DB. Analyzed the data: CR CG VW JMH RM PS KAK MD DB. Wrote the paper: CR CG VW JMH KAK MD TF PDS EAH JCB EK NRS DB.","CR, CG, VW, KAK, MD, NRS, DB, TF, PDS, EAH, JCB, and EK are full time employees of AstraZeneca. JMH, RM and PS are employees of NEO New Oncology AG. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","02","Claire Rooney","CR",15,TRUE,12,7,9,13,TRUE,TRUE,FALSE,0,NA,FALSE
